Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)
Trial details
- Registry ID
- NCT07579910
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)NCT07579910 | Spruce Biosciences | Phase 3 | Not yet recruiting | 2033-08Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |